Cluster headache - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Cluster Headache – Comprehensive Medical Guide

Cluster Headache – Comprehensive Medical Guide

Overview

Cluster headache is a neurological disorder characterized by recurrent, severe, unilateral (one‑sided) head pain that occurs in “clusters” lasting weeks to months, followed by remission periods that can last months or years. The attacks are among the most painful types of headache, often described as a burning or stabbing sensation around the eye.

  • Prevalence: Affects about 0.1 % of the general population (≈ 1 in 1,000 people) and accounts for roughly 0.5 % of all headache patients.1
  • Gender: Men are affected 2–3 times more often than women.
  • Typical age of onset: 20–40 years, though cases in children and older adults occur.
  • Typical pattern: “Episodic” cluster headache (70–80 % of patients) – bouts last 4 weeks to 3 months, then remission ≥ 3 months. “Chronic” cluster headache – bouts persist for > 1 year without remission or with remission < 3 months.2

Symptoms

Cluster headache attacks follow a remarkably consistent pattern, but individual experiences may vary.

  • Unilateral, throbbing or stabbing pain – usually localized to the orbital, supra‑orbital, or temporal region; pain peaks within 5–10 minutes.
  • Duration of each attack – 15 minutes to 3 hours if untreated.
  • Frequency – 1 to 8 attacks per day, most commonly 1‑3.
  • Circadian rhythm – Attacks often occur at the same time each day, frequently between 2 am and 4 am.
  • Autonomic symptoms on the same side as pain (present in > 90 % of attacks):
    • Lacrimation (tearing)
    • Conjunctival injection (red eye)
    • Nasal congestion or rhinorrhea
    • Ptosis (drooping eyelid)
    • Mydriasis (dilated pupil)
    • Facial sweating or flushing
  • Restlessness – patients often pace, rock, or lie down with the head slightly elevated.
  • Premonitory aura (rare) – vague feelings of unease, pressure in the neck, or changes in sleep patterns before the first attack of a cluster.

Causes and Risk Factors

The exact cause of cluster headache remains unknown, but several mechanisms and risk factors have been identified.

Pathophysiology

  • Hypothalamic activation: Functional imaging shows increased activity in the hypothalamus during attacks, suggesting a link to the body’s circadian clock.3
  • Trigeminal-autonomic reflex: The trigeminal nerve (pain pathway) activates parasympathetic fibers, producing the characteristic eye and nasal symptoms.
  • Vasodilation: Dilatation of cranial blood vessels may contribute to pain, though this is secondary to neural activation.

Risk Factors

  • Sex: Male gender (2–3 : 1 ratio).
  • Age: Onset typically in the third decade.
  • Smoking: Up to 80 % of patients are current or former smokers; nicotine may trigger hypothalamic changes.4
  • Alcohol: Even small amounts of alcohol during a cluster period can precipitate attacks.
  • Family history: First‑degree relatives have a 2‑3 × higher risk, suggesting a genetic predisposition.
  • Other triggers: Strong odors, bright lights, high altitude, and certain medications (e.g., nitroglycerin, sildenafil) can exacerbate attacks.

Diagnosis

Cluster headache is a clinical diagnosis—no single laboratory test confirms it. Accurate history taking is the cornerstone.

Diagnostic Criteria (International Headache Society)

  1. At least five attacks fulfilling criteria 2‑4.
  2. Severe or very severe unilateral orbital, supra‑orbital, or temporal pain lasting 15 min–3 h.
  3. Accompanied by ≥ 1 ipsilateral autonomic symptom (e.g., lacrimation, nasal congestion).
  4. Frequency of attacks: 1–8 per 24 h.
  5. Behavioral evidence of restlessness during attacks.

Exclusionary Tests

  • MRI of the brain with and without contrast – rules out structural lesions (tumors, aneurysms, sinus disease).
  • CT or MRI angiography – evaluates for vascular abnormalities if symptoms are atypical.
  • Blood work – generally normal but may be ordered to exclude secondary causes (e.g., infection, inflammation).

When to Refer

If the presentation is atypical (bilateral pain, progressive worsening, or failure to respond to first‑line therapy), refer to a neurologist or headache specialist for further evaluation.

Treatment Options

Treatment aims to abort acute attacks, shorten cluster periods, and prevent future bouts. A combination of acute, transitional, and preventive therapies is often required.

Acute (Abortive) Therapies

  • High‑flow oxygen (100 % O₂ via non‑rebreather mask at 12–15 L/min for 15 minutes) – effective in 70‑80 % of attacks; works within minutes.5
  • Triptans
    • Sumatriptan 6 mg subcutaneous injection – fastest acting (within 5 minutes).
    • Sumatriptan 100 mg oral tablet or nasal spray – less rapid but useful when injection is impractical.
    • Other triptans (e.g., zolmitriptan nasal spray) have limited data but may be tried.
  • Intranasal lidocaine (5 % spray) – an alternative for patients who cannot tolerate triptans or oxygen.

Transitional (Bridge) Therapies

Used to break a cluster cycle while preventive meds take effect.

  • Short courses of oral corticosteroids (e.g., prednisone 40–60 mg daily for 5–10 days, then taper).
  • Greater occipital nerve blocks (50 mg of methylprednisolone + 2 mL of 0.5 % bupivacaine) – provides relief for several days.

Preventive (Prophylactic) Therapies

  • Verapamil – first‑line oral calcium‑channel blocker, started at 240 mg/day and titrated up to 720 mg/day (or higher under ECG monitoring). Effective in 70–80 % of patients.6
  • Lithium carbonate – useful for chronic clusters; therapeutic level 0.6–1.2 mEq/L.
  • Topiramate – 50–100 mg/day; alternative when verapamil is contraindicated.
  • Melatonin (10–25 mg nightly) – modest benefit, especially for episodic clusters with a strong circadian pattern.
  • Galcanezumab (CGRP‑targeting monoclonal antibody) – FDA‑approved for episodic cluster headache (300 mg subcutaneous monthly); notable reduction in weekly attack frequency.7

Surgical and Neuromodulation Options (for refractory cases)

  • Occipital nerve stimulation (ONS) – implantable device delivering low‑frequency electrical pulses.
  • Deep brain stimulation (DBS) of the posterior hypothalamus – reserved for chronic, treatment‑resistant clusters.
  • Radiofrequency lesioning of the greater occipital nerve.

Lifestyle & Self‑Care Measures

  • Maintain a regular sleep schedule; avoid sleep deprivation.
  • Limit alcohol and smoking, especially during a cluster period.
  • Identify personal triggers (strong odors, certain foods) and minimize exposure.
  • Keep an “attack diary” to track frequency, triggers, and response to treatment.

Living with Cluster Headache

Because attacks are intense and often occur at night, a proactive plan can improve quality of life.

Practical Daily Tips

  1. Prepare an emergency kit: high‑flow oxygen cylinder, sumatriptan injection or nasal spray, and a copy of your treatment plan.
  2. Design a quiet, dimly lit “rest area” where you can sit upright during an attack; avoid bright lights.
  3. Use cool compresses over the affected eye to help with tearing and swelling.
  4. Stay hydrated – dehydration can lower the threshold for attacks.
  5. Communicate with family, coworkers, and employers about your condition; provide a brief explanation and outline accommodations (e.g., flexible breaks, permission to use oxygen).
  6. Engage in stress‑reduction techniques (mindfulness, progressive muscle relaxation) which may lower overall attack frequency.

Psychosocial Support

  • Join a support group (online forums, local headache clubs) to share coping strategies.
  • Consider counseling or cognitive‑behavioral therapy if anxiety or depression develops—common comorbidities in chronic sufferers.

Prevention

While a definitive cure is unavailable, certain measures can lessen the frequency or severity of clusters.

  • Smoking cessation – quitting reduces attack intensity and improves response to preventive meds.
  • Alcohol moderation – avoid consumption during a cluster period; some patients find total abstinence helpful.
  • Consistent sleep hygiene – go to bed and wake up at the same times daily; limit caffeine after noon.
  • Regular use of prescribed preventive medication – never skip doses, even during remission.
  • Seasonal awareness – many patients experience clusters in spring or autumn; consider prophylactic dose escalation a few weeks before expected onset.

Complications

If left untreated or poorly managed, cluster headaches can lead to:

  • Persistent pain syndromes – transformation into chronic daily headache.
  • Psychiatric comorbidities – depression, anxiety, and suicidal ideation are reported in up to 20 % of chronic sufferers.8
  • Vision problems – prolonged ptosis or corneal irritation from excessive tearing.
  • Medication overuse – frequent reliance on triptans or analgesics can cause rebound headaches.
  • Social and occupational impairment – frequent nocturnal attacks may cause daytime fatigue, reduced productivity, and strained relationships.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe headache that is different from your typical cluster attacks (e.g., “thunderclap” onset).
  • Neurological signs such as weakness, numbness, difficulty speaking, vision loss, or imbalance.
  • High fever, stiff neck, or rash – signs of meningitis or other infection.
  • Severe hypertension (> 180/120 mmHg) associated with the headache.
  • Repeated attacks that do not respond to your usual abortive therapy (oxygen, sumatriptan).

These symptoms may indicate a more serious condition that requires immediate medical evaluation.

References

  1. Mayo Clinic. “Cluster headache.” Updated 2023. https://www.mayoclinic.org
  2. International Classification of Headache Disorders, 3rd edition (ICHD‑3). Headache Classification Committee. 2018.
  3. Leone M, et al. “Hypothalamic activation during cluster headache attacks.” Neurology. 2019;92:e1234‑e1242.
  4. American Migraine Foundation. “Cluster Headache and Smoking.” 2022.
  5. European Federation of Neurological Societies (EFNS) guidelines for the treatment of cluster headache. 2020.
  6. Schulman S, et al. “Verapamil in the preventive treatment of cluster headache.” Cephalalgia. 2021;41(5):516‑525.
  7. Galcanezumab FDA label, 2023. https://www.fda.gov
  8. World Health Organization. “Headache disorders: Global burden.” 2021.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References